Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General cellular lipid and membrane compartments refer to the complex lipid bilayers and associated hydrophobic environments that constitute the structural boundaries of cells and organelles. These compartments are primarily composed of phospholipids, cholesterol, and sphingolipids, which provide a semi-permeable barrier and a matrix for membrane protein function (van Meer et al., 2008). While not a single molecular entity, they serve as critical therapeutic targets for various agents, particularly anti-infectives that exploit differences between host and pathogen membrane compositions (Epand & Epand, 2009). For example, certain antibiotics like daptomycin and antifungals like amphotericin B disrupt membrane integrity or form pores, leading to rapid cell death (Baginski & Tugnoli, 2005). Additionally, the physical state of the membrane, such as its fluidity and thickness, can modulate the activity of embedded receptors and ion channels (Franks, 2008). This makes the membrane a secondary or even primary target for lipophilic drugs like general anesthetics, which may alter the lateral pressure profile of the bilayer (Cantor, 1997). In disease states, changes in membrane lipid composition can lead to signaling dysregulation or increased susceptibility to oxidative stress (Maxfield & Tabas, 2005).
Drugs targeting these compartments typically act through physical disruption of the lipid bilayer, alteration of membrane fluidity, formation of transmembrane pores, or sequestration of specific lipid species like ergosterol or phosphatidylglycerol (Baginski & Tugnoli, 2005; Epand & Epand, 2009).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General cellular lipid and membrane compartments.